Founder and CEO, BlueReg Group
- European Regulatory Affairs
- Development and registration strategy
- FDA and European Regulatory Agency interactions
Corinne founded BlueReg in 2011 and since then, as CEO, has led the company to success with consistent year-on-year growth. BlueReg today employs more than 40 highly experienced consultants committed to provide high quality services.
Corinne has extensive experience in international regulatory affairs after holding a range of positions during her 25 years in the pharmaceutical industry. She has expertise in a broad range of regulatory activities including development and registration strategy and the full spectrum of regulatory agency interactions both pre- and post-authorisation.
Previously, Corinne led European and international regulatory affairs at Allergan.
In addition to overseeing a group of more than 20 regulatory affairs professionals and their associated activities, Corinne provided regulatory strategy to global development project teams and managed a comprehensive array of successful European regulatory agency submissions.
Prior to this, Corinne held positions at several pharmaceutical companies including Roche and SmithKline Beecham. During this time, in addition to being involved in the registration of a wide range of new drugs, she obtained experience in the compliance aspects of commercial and promotional activities.